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Abstract: The application of metallic nanoparticles (MNPs), especially that of silver, gold, cobalt, and
zinc as antimicrobial, anticancer, drug delivery, contrast, and bioimaging agents has transformed the
field of medicine. Their functions, which are attributed to their physicochemical properties, have
gained prominence in various technological fields. Although MNPs can be produced via rigorous
physical and chemical techniques, in recent years, a biological approach utilizing natural materials has
been developed. With the increasing enthusiasm for safe and efficient nanomaterials, the biological
method incorporating microorganisms and plants is preferred over physical and chemical methods
of nanoparticle synthesis. Of these bio-entities, plants have received great attention owing to their
capability to reduce and stabilize MNPs in a single one-pot protocol. South Africa is home to ~10%
of the world’s plant species, making it a major contributor to the world’s ecological scenery. Despite
the documented contribution of South African plants, particularly in herbal medicine, very few of
these plants have been explored for the synthesis of the noble MNPs. This paper provides a review
of some important South African medicinal plants that have been utilized for the synthesis of MNPs.
The enhanced biological properties of the biogenic MNPs attest to their relevance in medicine. In this
endeavour, more of the African plant biodiversity must be explored for the synthesis of MNPs and
be validated for their potential to be translated into future nanomedicine.
Keywords: green nanotechnology; metallic nanoparticles; medicinal plants; antimicrobial; cytotoxicity;
green synthesis
1. Introduction
Over the years, MNPs (at a size range between 1 and 100 nm) have fascinated scien-
tists and are currently utilized in various fields not limited to medicine, agriculture, and
engineering [1–3]. The widespread practical applications of nanomaterials are attributable
to their unique optical, catalytic, electronic, and physical properties [4,5]. The synthesis of
MNPs with desired characteristics can be achieved via a variety of physical and chemical
processes [6–8]. However, these methods are elaborate, expensive, time-consuming, and
potentially hazardous to the environment and living organisms. The urgency to minimize
the potential negative impacts of the nanomaterials synthesized via physical and chemical
routes has led to the exploration of biological entities. The capability of microorganisms
and plants to transform metal ions into MNPs revealed a simple, rapid, cost-effective,
and eco-friendly approach for nanoparticle synthesis [9–11]. Microorganisms, including
bacteria, fungi, and yeasts, can reduce metallic salts into nanoparticles (NPs) [12–14]. These
microbes produce proteins, enzymes, reducing cofactors, peptides, and organic materials
that play significant roles in the reduction of metallic salts into MNPs. These molecules
can serve as either reducing and/or capping agents. In this regard, numerous microorgan-
isms including Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and Candida
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albicans have been used for the synthesis of MNPs [13,15,16]. Plants are by far the most
important biological components for MNP synthesis, as their universal abundance and
lack of pathogenicity offer an advantage over other biological sources. Plant-mediated
synthesis is relatively mild, eco-friendly, cost and time effective; with their phytochemicals
and bioactive contents acting as reducing, capping, and stabilizing agents [17,18]. Conse-
quently, natural resources are conserved, and, at the same time, opportunities are created
for sustainable development. Numerous studies have reported the successful synthesis of
biogenic NPs using different plant species [6,8,19]. At their nanoscale size, the NPs exhibit
significantly different characteristics, as well as improved bioactivity, compared to their
bulk counterpart [6,20]. Despite the increasing awareness and promising benefits reported
for plant-mediated NPs, this area of research remains underexplored. Of a fact, more than
80% of the world’s population rely on herbs/medicinal plant for treating diverse kinds of
diseases, including diabetes, high blood pressure, cancer, and tuberculosis [21]. Moreover,
nearly 60% of all synthetic drugs used for clinical purposes are derived from plants which
further justifies the significance of medicinal plants [22].
South Africa houses about 10% of the world’s plant species, with over 3000 plants
reported to have significant medicinal benefits [23]. Despite this biodiversity and the
promising benefits of plant-mediated MNPs, the utilization of South African medicinal
plants for the synthesis of MNPs is still largely underexplored [24]. Recently, indigenous
South African plants including Salvia africana-lutea [6], Sutherlandia frutescens [6], Galenia
africana [25], Catharanthus roseus [26], Hypoxis hemerocallidea [27], Cotyledon orbiculata [28],
and Aspalathus linearis [29] were utilized for the fabrication of MNPs. These MNPs with
sizes ranging from 5–50 nm were reported to exhibit high antibacterial activities compared
to their respective plant extracts. Therefore, considering the vast potential of plants as alter-
native sources of reducing agents with enhanced bioactivities, continuous research towards
the exploration of South African medicinal plant reserves will be of paramount importance.
The present review provides a brief overview of some potent South African medicinal
plants utilized for nanoparticle synthesis. Characterizations, as well as the biological appli-
cations of the biogenic MNPs, were highlighted. With this update, rigorous research could
be directed towards African medicinal plants to produce natural and effective nanoprod-
ucts that will revolutionize many technologies and industries, including pharmaceuticals,
food, cosmetics, construction, medicine, engineering, and many others.
2. MNPs and Their Application
Nanotechnology is an important aspect of science that relies on the synthesis, modifica-
tion, modulation, and application of materials within the nanometer scale (1–100 nm) [30–32].
NPs have attracted much interest in the last decades due to their distinct physicochemical,
optical, magnetic, and biological properties [30]. Their properties, predominantly convened
by their large surface area to volume ratio and size, are absent in bulk materials. Conse-
quently, these unique properties are explored for application in environmental, water, food,
biomedical, and space industries [4,33]. MNPs particularly those of noble metals such as
silver and gold NPs have been widely explored in various biomedical fields [34] not limited
to tissue engineering, health care, drug delivery, and gene delivery [34–36]. This section
will give a brief overview of some of the most widely used MNPs and their application.
2.1. Silver NPs (AgNPs)
AgNPs have drawn considerable research interest due to their superior physical, chem-
ical, and biological characteristics [26,37,38]. Rigorous efforts have been made to explore
their integral properties for practical and clinical applications, particularly, as therapeutic
and diagnostic agents [27,28]. Previous and recent discoveries have shown that AgNPs
exhibit interesting antimicrobial effects against a wide range of microorganisms [6,28].
AgNPs are thus used in water purification and wound dressing as antimicrobial agents [35].
Their use for the production of paints, disinfectants, and some kitchen appliances has also
been reported [37,39]. The therapeutic applications of AgNPs in terms of their antiviral,
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antifungal, anticancer, and antibacterial properties have also been demonstrated [6,27,28].
Currently, AgNPs are commercialized as antimicrobial agents in the pharmaceutical and
cosmetic industries and are also utilized to protect against infections in various medical
implants or bone cement [40,41].
2.2. Gold NPs (AuNPs)
AuNPs, on the other, hand have attracted significant interest over the last decades ow-
ing to their optical and chemical properties. Their potential as diagnostic and therapeutic
agents in a variety of medical fields has been documented [42–44]. AuNPs are used as drug
carrier/delivery, bioimaging, contrast, photothermal, and anti-angiogenic agents [45,46].
AuNPs were investigated for antibacterial activity and found to display an effective an-
tibacterial effect against gram-positive and gram-negative bacterial strains [47–50]. AuNPs
can ferry and deliver hydrophobic and hydrophilic drugs, peptides, antibodies, and small
molecule drugs to the targeted tumour site with no toxic effects on normal or surrounding
tissues [51]. Moreover, AuNPs provide a platform to attach multiple moieties on their
surface, therefore, they are suitable as drug delivery agents [4,52]. AuNPs can be function-
alized with therapeutic moieties to exhibit enhanced anticancer effects [51,53]. Additionally,
strategies that involve attaching targeted peptides that would possibly target receptors that
are exclusively expressed by diseased cells have been reported [53]. AuNPs-conjugates
were reported to significantly enhanced the selectivity as well as the sensitivity of thera-
peutic peptides on pancreatic (Panc-1) and colon (Caco-2) cancer cells [53,54]. According to
previous and recent studies, biosynthesized AuNPs have achieved significant targeting
and selectivity against a variety of cancer cells without any additional molecules [19]. A
study by Majoumouo et al. [19] demonstrated that the AuNPs synthesized using Termi-
nalia mantaly exhibited enhanced cytotoxicity and selectivity on Caco-2, epithelial breast
(MCF-7), and liver (HepG2) cancer cells. Another study by Anadozie and co-workers [19]
revealed that AuNPs synthesized from water extract of Xylopia aethiopica showed excellent
anticancer activity on MCF-7 and Caco-2 cells. These reports and many more have opened
a limitless opportunity towards the incorporation of AuNPs in molecular diagnostics
and therapy.
2.3. Metal Oxide NPs
Copper and copper (II) oxide NPs have found diverse applications in physics and
material science engineering. They are strong antimicrobial agents exhibiting excellent
disinfecting properties against several infectious organisms [55]. The application of iron
oxide NPs in many biomedical applications like gene therapy, stem cells, cancer, and
atherosclerosis has been reported [56]. These NPs have been developed as anticancer,
antifungal, antimicrobial, and targeted drug delivery agents. Zinc oxide (ZnO) NPs are
popularly known for their antimicrobial and anticancer activities. They have been found
useful in food packaging, wastewater treatments, and some personal care products [13].
ZnO NPs were used as preservatives in food packaging to prevent and inhibit the growth
of microbes on food materials. Moreover, ZnO NPs proffer toxicity against microorganisms
compared to all other metal oxides NPs.
3. Synthesis of MNPs
Consequent to the continuous utility of MNPs in several modern-day applications,
the method for their preparation needs to be safe to achieve better control of desirable
physicochemical and bio-functional properties. Several methods and modifications have
been explored for their synthesis [14]. Over the years, NPs have continuously been used
and modified to enable their application in various fields ranging from agriculture and
biomedicine. The techniques developed for the synthesis of NPs are classified as top-down
and bottom-up. The top-down approach reduces bulk material of interest to NPs, while
the bottom-up approach build-up smaller material into the required nanostructure [32].
Further, these techniques are classified into physical, chemical, and biological methods
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of NP synthesis as depicted in Figure 1. Physical methods mainly operate on a top-
down strategy where bulk materials are systematically broken down bit by bit to produce
finely divided NPs [4]. The physical methods rely on mechanical pressure, electrical
and radiation energy, melting, evaporation, or condensation techniques to produce NPs.
Examples include vapor condensation, aerosol, laser ablation, pyrolytic, high-energy ball
milling, laser pyrolysis, inert gas condensation, and mechanical crushing processes [4]. The
chemical methods involve the use of organic and inorganic substances, including sodium
citrate, elemental hydrogen, sodium borohydride, hydrazine, dimethylformamide, and
ascorbate as reducing agents for the synthesis of the NPs. Sol-gel, hydrothermal, chemical
vapour deposition, microemulsion, and polyol techniques are the commonly used chemical
methods [4].
Figure 1. Methods used for the synthesis of MNPs. The different methods are classified as top-down
and bottom-up. Adapted from [4].
Although the physical and chemical approaches are the most popular, they are costly,
time-consuming, and require sophisticated working conditions. Moreover, their applica-
tion, particularly in biomedicine, is threatened with toxicological effects on humans, ani-
mals, and the environment [57,58]. The search for non-toxic and environmentally friendly
protocols which do not use hazardous chemicals and complicated physical techniques
in NP synthesis has led to the exploration of biological entities. Thus, microorganisms
and plants have emerged as green agents, providing eco-friendly routes for the synthesis
of NPs.
3.1. The Advent of Green Nanotechnology
Green nanotechnology is an exciting and emerging area of science and technology that
embraces the principles of green chemistry with potential benefits towards sustainability,
protection, and overall safety of the human race [59]. The green chemistry methodol-
ogy introduces a desirable approach to the synthesis, processing, and application of less
hazardous chemicals to reduce threats to human health and the environment [60]. The
approach requires an in-depth understanding of the raw materials, especially in terms of
their fabrication into nanomaterials and the resulting bioactivities that pose little or no
hazardous effects on humans and the environment. On this note, nanomaterials can be
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engineered from natural sources at our disposal with the assurance of minimized potential
risks. The use of biological entities as reducing, capping, and stabilizing agents in the
synthesis of MNPs is constantly gaining wide attention [25]. The method utilizes microor-
ganisms, and plant products as reducing agents [11], presenting benign and eco-friendly
conditions that can improve safety in humans and animals [31].
The exploration of microorganisms such as bacteria, fungi, algae, and viruses as
reducing agents for MNP synthesis is becoming more popular among natural product
researchers. Microorganisms reduce metallic ions into their corresponding NPs with
the help of enzymes produced by their cellular metabolism in two ways. (1) Intracellular
pathway, where the metal ions are trapped and reduced inside the microbes (2) extracellular
pathway, where the ions are reduced on the microbial cell surface or in the medium [5,12].
Fungi, which are sometimes referred to as “bio-nano factories,” have reportedly been
used to reduce gold ions to AuNPs because of their capability to secrete large amounts of
enzymes and their ability to withstand metal toxicity to a more considerable extent [13].
Yeast, such as C.albicans and algae such as Sargassum wighti have been successfully
used to synthesize stable AuNPs making them good candidates for NP production [30].
Bacteria are also potential bio-factories for NP production, as they can withstand stress
exerted by heavy metal toxicity. Some bacterial cultures such as Pseudomonas stutzeri,
P. aeruginosa, Thiobacillus ferrooxidants, and E. coli were used to synthesize monodispersed
MNPs with excellent biomedical applications [2,61]. In another study, the culture super-
natants of K. pneumonia, E. coli, and Enterobacte cloacae were used as reducing agents
for the rapid biosynthesis of AgNPs [47,61]. Microorganisms have undeniably provided
MNPs with significant antimicrobial and anticancer properties [12]. However, the elaborate
experimental procedures in terms of isolation, culture preparation, and maintenance have
strained this approach. This limitation and others have upsurged the synthesis of MNPs
using plant sources. Thus, plant-mediated synthesis is becoming most prominent, offering
a quicker and more manageable approach than microbial and other green sources [2,10,34].
The potential of plants to bioaccumulate heavy metals suggests their use in the trans-
formation of metal ions into MNPs. Alfalfa sprouts were the first plant reportedly used for
the synthesis of AgNPs [62]. Subsequently, different plant species along with a variety of
bioactive compounds have been explored for the production of MNPs including gold, silver,
zinc, iron, copper, and platinum. Studies have shown that the reduction and stabilization
of MNPs are achieved through the action of diverse compounds like proteins, amino acids,
polysaccharides, and phytochemicals like flavonoids, alkaloids, tannin, and polyphenols
present in the plants [63,64]. With the plant-derived approach, synthesis and purification
are quicker and easier compared to the microbial-mediated approach [2,62].
3.2. The Synthesis of Plant-Mediated MNPs
The notion that plants can bio-accumulate and reduce metal ions has opened options
for considering their use as an alternative route for the synthesis of MNPs. The plant-
mediated synthesis of NPs offers advantages over the microbes-mediated approach in
simplicity, cost-effectiveness, rapidity, and non-pathogenicity [64]. Several plants including
Zingiber officinale, Punica granatum, Acalypha indica, Ficus benghalensis, Galenia africana,
Terminalia mantaly, and Catharanthus roseus have been reportedly used for the synthesis
of MNPs. The synthetic process is initiated by the addition of extracts obtained from
plant parts such as leaves, flowers, roots, stems, bark, and fruits into the aqueous solution
of metal ions [8]. The phytochemicals present in the plant extracts which include sugar,
flavonoids, protein, enzyme, polymer, and organic acid, act as reducing and stabilizing
agents. The alkaloids, polyphenols, terpenoids, polysaccharides, amino acids, organic acids,
vitamins, and heterocyclic compounds are implicated in the bioreduction process [64], and
equally, play significant roles in the capping and stabilization of the bio-synthesized NPs.
The exact mechanism and the plant components responsible for plant-mediated synthetic
NPs remains complicated [8,19,20]. Several potential mechanisms have been proposed [65]
as shown in Figure 2. During NP synthesis, a bioreduction phase occurs where bioactive
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compounds present in the plant extracts reduce metal ions/salts from their mono or
divalent oxidation states to zero-valent states [66]. Subsequently, the reduced metal atoms’
nucleation indicated by physical observation of a colour change in the reaction medium
takes place. As bioreduction and nucleation continue, a growth phase is reached where
smaller particles mechanically interact to form larger particles that are thermodynamically
more stable. The final stage of the synthesis is the termination stage, where the bioactive
compounds exert their stability potentials and finally define the shape and morphology of
the NPs.
Figure 2. Synthesis of MNPs using plant extracts. Several plant extracts with high reductive capacity actively reduce
metallic ions including silver, zinc and gold ions to their corresponding MNPs. Adapted from [20].
Reports suggest that the mechanisms employed in the process of preparing NPs
from medicinal plants differ from plant to plant due to the variation in their bioactive
molecules, their composition and concentration [6]. The variation between plants and their
subsequent interaction with aqueous metal ions as well as factors such as pH, temperature,
and reaction time results in NPs exhibiting different physical, chemical, and biological
properties [8]. Moreover, the properties of the phytochemicals present in the plants play the
most vital role in the bioactivities of the NPs [28]. It is believed that the NPs derived from a
particular plant extract may take on the bioactivities displayed by the plant extract [20]. In
most cases, the NPs have a superior or higher bioactivity than the plant extract [19]. Such
NPs can be engineered as nanoplatforms for molecular diagnosis, effective and targeted
delivery of drugs, providing treatments of diseases that can resolve some of the drawbacks
associated with traditional medicine [20]. These NPs have the potential to be translated
into conventional medicine much faster, hence overcoming the many challenges associated
with present-day standard modes of treatment.
4. Biological Application of MNPs Synthesized from Some Selected South African
Medicinal Plants
4.1. South African Medicinal Plant Biodiversity
Africa is a continent endowed with remarkable natural biodiversity with over
45,000 different plant species documented [21]. In a comprehensive list containing African
medicinal plants, only about 5400 plants have been reported to have medicinal properties.
This represents approximately 12% of the total African plants and therefore supports the
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claim that African plants are under-utilized for medicinal purposes. The interest in Africa’s
underexplored medicinal plants has recently upsurged; over 60% of recent publications
focused on the African medicinal plants and their bioactivities [21]. Despite the increasing
research interest, the commercialization of African plants still lags. A global review of com-
mercialized medicinal plants revealed that only 83 African medicinal plants are considered
partially or fully commercialized [23], whereas, in Europe and Asia, commercialization
is at its maximum peak. Plants have been a major source of medicines in most African
countries for thousands of years [67,68] and have played an integral role in basic traditional
medicine and healthcare in many developing countries, including South Africa.
South Africa is the third most biodiverse country, and houses one of the world’s six
floral kingdoms (the Fynbos Biomes) in addition to other biodiversity hotspots, the Succu-
lent Karoo and the Albany-Maputaland corridor [23,69]. Figure 3 shows the floristic region
of South Africa. According to the “African Plant Checklist and Database Project”, Sub-
Saharan Africa houses 50,136 angiosperm taxa, out of which Southern Africa accounts for
22,755 taxa [23]. Moreover, South Africa hosts around 30,000 flowering plant species with
over 3000 plants reported to have medicinal uses [21,68]. The global review of commercial-
ized medicinal plants shows that South Africa accounts for 14 out of the 83 commercialized
African medicinal plants [70]. The most valuable of all indigenous South African plants
is the Aloe vera L. while those that have received universal recognition include Agathosma
betulina, Aloe ferox, Aspalathus linearis, Harpagophytum procumbens, Hypoxis hemerocallidea,
Merwilla natalensis, pelargonium sidoides, Sclerocarya birrea, and Cyclopia intermedia.
Figure 3. Catalogue of some of the indigenous plants found in the Cape Floristic Region of South Africa.
4.2. MNPs Synthesized from Indigenous SA Plants and Their Application
Medicinal plants have a long history in traditional medicine; over 80% of the South
African population relies on the plants to meet their primary health care needs [68]. Medic-
inal plants offer differential therapeutic properties based on their integral supply of sec-
ondary metabolites, viz, flavonoids, alkaloids, phenolics, terpenoids, tannins, glycosides,
quinones, steroids, and saponins [71]. However, most of these compounds have low absorp-
tion, resulting in a loss of bioavailability and efficacy due to their inability to cross the lipid
bilayer of cells [72]. Thus, several phytochemical and pharmacological investigations of
these plants and their derivatives revealed impressive in vitro activity and less in vivo effi-
cacy. To facilitate effectiveness, one approach that is increasingly suggested in the literature
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is the combination of traditional medicinal plants with nanotechnology [73,74]. Nanotech-
nology is one of the newest approaches with the potential to revolutionize the medical
and pharmaceutical fields [19,20,74]. The incorporation of nanosystems in herbal medicine
could serve as an effective tool in eradicating the limitations associated with medicinal
plants [75]. With the emerging new technologies, these plants can be formulated into
newer strategies that can enhance the delivery and efficacy of their phytochemicals [76].
Green nanotechnology has shown great promise in this regard and various medicinal
plants have been reportedly used to synthesize MNPs with enhanced biocompatibility and
biological activities [18,49]. Hembram et al. [77] reported the synthesis of AgNPs using
aqueous leaf extracts of Mentha pulegium, Coriandrum sativum, and Prosopis cineraria. This
particular study reported that the biogenic AgNPs showed an enhanced anticancer effect in
in vitro breast cancer cells [77]. Due to the excellent pharmacological activities displayed by
plant mediated MNPs, focus on how traditional plants would benefit the pharmaceutical
industry especially in the drug discovery platform is now paramount.
South Africa is rich with a plethora of plants with a long history in traditional medicine
for the treatment of infectious and chronic diseases, necessitating their inclusion in nan-
otechnology. The exploration of South African medicinal plants including Camellia sinensis,
Azadirachta indica, Aloe vera, and Jatropha curcas plant extracts for the synthesis of a variety
of MNPs has been documented. Moreover, a largescale screening of plant species obtained
from the Cape floristic region of South Africa including Aspalathus hispida, Indigofera brachys-
tachya, Nidorella foetida, and Podocarpus falcatus was successfully used for the synthesis of
AuNPs [8]. Interestingly, the investigations regarding the activities of South African plant-
mediated MNPs revealed enhanced antimicrobial and anticancer activities compared to the
crude plant extract [6]. Despite the number of valuable indigenous plants utilized for MNP
production, only very few of them have been explored for biological purposes. Therefore,
the present study reviews 12potent plants commonly used in South Africa traditional
medicine in terms of their potential for MNPs synthesis and their biological applications.
Some of these plants are indigenous, while others are also found in other parts of the world.
A list of some selected South African plants incorporating their traditional use for treating
various ailments and their bioactivity through green nanotechnology is given in Table 1.
Table 1. List of selected South African medicinal plants utilized for MNP synthesis and their biological activity.
Plant Species Indigenous Application Major Phytochemicals MNPs MNP Size(nm) MNP Bio-Activity
Cyclopia intermedia
Treat constipation, nervousness,
cough, eczema, epilepsy and




AuNPs 20 Anticancer [20]
Sutherlandiafructecens
Treat wounds, cancer, diabetes,
skin diseases, rheumatism,
urinary tract infection, fever,















Immune booster, purgative, and
laxative tonic
Treat tuberculosis, urinary tract
infection, infertility, cancer,
diabetes, and wounds [82,83]
Sterols, norlignane,
daucosterols, stanols, hypoxide,






Reduce fever, urinary diseases,
stomach, lower backaches,
syphilis and sometimes used to
induce labour [84,85]
Homoisoflavanones, terpenoids,
and diben-α-pyrones [85] AgNPs 56 Antimicrobial [86]
Plumbago auriculata








AgNPs 15.22 Antimicrobial [7]
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Table 1. Cont.
Plant Species Indigenous Application Major Phytochemicals MNPs MNP Size(nm) MNP Bio-Activity
Catharanthus roseus
Treat rheumatism, venereal






























Epilepsy, asthma, stomach ache,
bronchitis, and some skin
diseases [95]
Saponins, alkaloids, flavonoids,





















Consumed as a vegetable and







AgNPs 30–50 Antimicrobial [104]
Galenia africana
Treat venereal sores, eye
infections, asthma, tuberculosis,
cough, wounds, skin infections





AuNPs 9–27 Antibacterial [25]
Sclerocarya birrea Treat dysentery, rheumatism,malaria, and diarrhea [107,108]
Glucosides, steroids, glycosides,
flavonoids, fatty oils, alkaloids,
phenols, resins, calcium,
phosphorus [107,108]
AgNPs 112 Antimicrobial [86]
4.2.1. Cyclopia intermedia
C. intermedia, commonly known as Honeybush (HB), is a popular South African shrub
belonging to the family Fabaceae. The plant is an erect, much-branched shrub found in
winter rainfall coastal and mountainous areas with a moderate Mediterranean climate [109].
It is a perennial plant with a woody stem that grows up to 1.5 to 3 m tall. HB is characterized
by yellow flowers, long needle-like leaves with a honey-like smell [92,93]. The leaves and
stems are used to brew the famous South African herbal HB tea known for several health
benefits. Traditional healers from South Africa use the infusion prepared from the leaves
and stem to relieve constipation, nervousness, cough, eczema, epilepsy, and to regulate
blood pressure [21]. HB tea is caffeine-free and contains low tannin, making it a suitable tea
that can be drunk at bedtime. The health benefit of HB include prevention of skin cancer and
lowering of blood glucose levels [110]. Additionally, HB offers phytoestrogenic properties
against breast cancer by binding to oestrogen receptor subtypes, thus, prevents the growth
of breast cancer cells [111]. Its anticancer effects are through its modulation of oxidative
stress, inhibition of cell proliferation, and adenosine triphosphate (ATP) production [111].
Studies showed that HB extracts contain polyphenolic compounds which are correlated
with the plant’s biological activities. The significant compounds, characterized and isolated
from HB, are the xanthones (MGF and isomangiferin) and flavanones (hesperidin, and
isosakuranetin) [78,79]. These polyphenols offer the HB plant the ability to improve the
immune system, protect against inflammatory diseases, and inhibit antimicrobial and
tumour growth [110,111].
The synthesis of AuNPs using HB extracts (HBE) has been previously documented [20].
Using an eco-friendly approach, water extract of HB leaves was used to synthesize HB-
AuNPs. The UV-Vis spectroscopic analysis showed that the biogenic HB-AuNPs displayed
distinct peaks at 540 nm with a hydrodynamic diameter of 66.74 nm. The XRD analysis
confirmed that the biogenic HB-AuNPs were crystalline. The average core size of the
HB-AuNPs as determined by transmission electron microscope (TEM) was found to be
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20 nm, exhibiting predominantly spherical with some triangular-shaped AuNPs. The FTIR
analysis clearly showed the formation of AuNPs and indicated that HBE contains various
phytochemicals, particularly polyphenols such as MGF, which could have been one of
the phytochemicals that acted as reducing and stabilizing agents for the HB-AuNPs. A
further study showed that the HB-AuNPs exhibited selective toxicity against brain (U87),
prostate (PC-3), and colon (Caco-2) cancer cells [20]. These effects were compared and
found similar to the effects of AuNPs synthesized from MGF (MGF-AuNPs). Thus, the
study strongly suggests that MGF is possibly one of the reducing agents for the synthesis of
HB-AuNPs [20]. Interestingly, the anticancer effects of both HB-AuNPs and MGF-AuNPs
were further augmented when used in combination with doxorubicin [20]. Importantly,
the study further investigated the effect of the HB-AuNPs and MGF-AuNPs on normal
breast epithelial (MCF-12A) cells and showed that the biogenic MNPs had no toxicity
on the cells even at the highest concentration of 1000 µg/mL [20]. This observation was
consistent with earlier study that showed that 100 µM AuNPs synthesized using MGF
(MGF-AuNPs) isolated from leaf extracts of M. indica L had no toxic effect on normal
epithelial breast (MCF-10A) cells [51]. Similarly, Majoumouo et al. [19] showed that
AuNPs synthesized using water extract of T. mantaly showed no significant reduction
in cell viability of non-tumourigenic skin fibroblast (KMST-6) cells after 24 h treatment.
Consequently, these findings present useful information in understanding the therapeutic
application of biogenic MNPs, particularly in MNP formulations and dosage regimen.
4.2.2. Sutherlandiafructecens
S. frutescens is an indigenous South African medicinal plant found predominantly in
the Eastern, Northern, and Western Cape provinces, and some areas of KwaZulu-Natal.
It is an attractive leguminous shrub that can grow from 0.5 m up to 1.2 m in height.
Also, it has greyish-green leaves finely arranged in a feather-like feature. S. frutescens is
characterized by transparent bladder-like fruits, large balloon-like seed pods, and orange-
red flowers. Traditional healers in South Africa use decoction prepared from S. frutescens
(leaves, stems, flowers, roots, and pods) to treat wounds, cancer, diabetes, rheumatism,
influenza, gonorrhoea, and to reduce body temperature [6,80]. The plant is also used to
alleviate diverse kinds of symptoms and conditions like depression and stress. Further, the
plant is used to treat urinary tract infections, stomach infections, skin diseases, gonorrhea,
kidney and liver problems [81]. The plant has been formulated into capsules, tablets, gels,
ointments, and creams, and available in some pharmacies and herbal shops [112].
The phytochemical profile of the plant revealed the presence of saponins, pinitols,
flavonoids, and triterpenoids, which are believed to be responsible for its enormous medic-
inal activities. Additionally, cannavanine, cycloartane glycosides, and flavonol glycosides
are also abundantly present in the plant, contributing significantly to its bioactivity [80].
Pharmacological studies of S. frutescens extracts revealed evidence of its antiviral, anti-
inflammatory, antibacterial, antiproliferative, antimutagenic, antioxidant, and antidiabetic
properties [112,113]. An improved quality of life reported in HIV patients following treat-
ment with commercial Sutherlandia tablets further expounded the popularity of the plant
as an effective herbal product [113]. An earlier study reported a dose-dependent decrease
in cell number and changes in the morphology of human breast cancer (MCF-7) cells fol-
lowing treatment with an aqueous extract of S. fructescens [113]. Moreover, the leaf extracts
of S. frutescens reduced insulin levels and enhanced glucose uptake in streptotozin-induced
diabetes in Wistar rats [114]. Owing to the acclaimed medicinal benefits, it is imperative to
investigate the fabrication of S. frutescens extracts into MNPs for enhanced bioactivity.
S. fructescens was first reported for the synthesis of Zinc Oxide (ZnO) NPs [81]. In
this particular study, the water extracts of the plant were used to reduce zinc salt for the
synthesis of ZnO NPs. The exact mechanism by which the ZnO NPs were formed is not
yet fully understood. It was proposed that phytochemicals present in the plant donated
hydrogen atoms, which resulted in the release of Zn2+ ion. Afterward, the Zn2+reacted with
the polyphenols of the plant, resulting in the formation of ZnO NPs. The FTIR measurement
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revealed a vibrational peak at region 1400 cm−1 which corresponds to biomolecules that
are involved in the formation of the ZnO NPs. The TEM images revealed spherical-shaped
NPs with the core size ranging between 5 and 25 nm. The antibacterial investigation against
E. coli, S. aureus, P. aeruginosa, and E. faecalis using agar well diffusion assay revealed that
S. frutescens ZnO NPs inhibited the growth of all test strains. Although this particular
study reported an impressive antibacterial activity for S. frutescens ZnO NPs, however, the
mechanism of the antibacterial effect was not fully captured. Evidence shows that NPs
can pass through the membrane to interact with cellular components of the bacterial cell
wall, thus induce oxidative stress that subsequently leads to cell death (Figure 4). The S.
frutescens ZnO NPs also exhibited a dose-dependent effect in lung (A549) cancer cells with
approximately 93.4% cell death following a 24-h treatment [81]
Figure 4. Mechanism of ZnO NPs against bacterial strains. ZnO NPs exhibited remarkable inhibition
of cell growth and cell death in bacterial strains following the direct interaction between the ZnO
NPs and the bacterial cell surface. Adapted from [81].
S. frutescens leaf extracts were also used in the synthesis of AgNPs following incu-
bation of water extract of S.frutescenswith AgNO3 in a simple and easy method [6]. The
S. frutescens AgNPs were predominantly spherical and polygon-shaped and had an average
core size between 15 and 20 nm. The various shapes and sizes indicated that more than
one phytochemical was involved in the reduction and possibly capping of the AgNPs. This
claim was validated by the overlapping peaks in the FTIR spectra of the extracts and the
AgNPs. While the water extract S. frutescens showed antibacterial activity at concentrations
up to 50 mg/mL, the biogenic AgNPs displayed a significant bacterial growth inhibition
against S. epidermidis and P. aeruginosa. The minimum inhibitory concentration (MIC, low-
est concentration that inhibits visible growth) of the AgNPs was ~66 fold lower than the
concentration of the plant extract (50 mg/mL) that failed to inhibit growth [6].
4.2.3. Hypoxis hemerocallidea
H. hemerocallidea of the hypoxidaceae family is an indigenous Southern African plant,
found abundantly in South Africa, Swaziland, Lesotho, and Botswana. The plant, com-
monly known as ‘African potato’, ‘miracle plant’, ‘molic’, and ‘star flower’ is enlisted in
Southern Africa as an indigenous medicinal plant with potential health benefits [83]. The
plant is characterized by strap-like hairy leaves, yellow star-shaped flowers, and thick
green hairy stems. Currently, H. hemerocallidea is commercialized as a natural product with
potent applicability in drug development [23]. The traditional use of H. hemerocallidea as a
strengthening tonic, purgative, and laxative, or to treat tuberculosis, urinary tract infec-
tion, infertility, cancer, diabetes, and wounds has been documented [82]. The promising
anticancer properties reported for H. hemerocallidea prompted its inclusion as one of the
South African plants used for the treatment of cancer in the Eastern Cape Province of South
Africa. The popularity of the plant became more prominent following its recommendation
for human immunodeficiency virus (HIV) patients as an immune booster [23].
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The plant is composed of hypoxoside, which is believed to be the main component
responsible for its numerous medicinal activities. Sterols, norlignane, daucosterols, stanols,
hypoxide, sterolins, and β-sitosterol are also reported to play significant roles in the
plants’ therapeutic activities. Also, H. hemerocallidea is laced with trace elements including,
copper, zinc, and manganese, thus used as pro-fertility supplements. Evidence-based
laboratory investigation indicated that extracts obtained from African potato possess nu-
merous pharmacological properties including antidiabetic, anti-inflammatory, antioxidant,
antihypeglycemic, analgesic, and anticancer [83].
The interesting biological properties entrusted in this plant led to its fabrication into
MNPs with enhanced bioactivity. The aqueous leaf extract of H. hemerocallidea was explored
in the synthesis of AuNPs (Hy-AuNPs). The reduction of the gold salt was achieved by
the phytochemicals that contain the O-H, CH3, and C-O functional groups commonly
found in flavonoids, terpenoids, carbohydrates, and phenolic compounds. The resulting
AuNPs with hydrodynamic size range from 10–45 nm displayed selective effect against
P. aeruginosa, S. epidermidis, E. coli, and S. aereus [27]. In another study, Elbagory et al. [27]
compared the physicochemical properties of the Hy-AuNPs with AuNPs synthesized
using water extract of hypoxoside (a compound isolated from H. hemerocallidea) and found
that they were similar. This suggests that hypoxoside is involved in the synthesis of
Hy-AuNPs. Furthermore, both AuNPs had immunomodulatary effects and reduced the
pro-inflammatory cytokines in macrophages (THP 1) and natural killer (NK-92) cells [27].
A recent study by Aremu et al. [115] reported the successful synthesis of AgNPs using
ethanolic extracts of H. hemerocallidea. The study showed that the resulting AgNPs with
an average diameter of 6–20 nm exhibited significant antibacterial activity against Bacillus
cereus, Streptococcus pneumonia, P. aeruginosa, Moraxella catarrharis, and E. coli. Interestingly,
a combined effect of the AuNPs with a broad-spectrum antibiotic, streptomycin, showed
that the AuNPs synergistically enhance the antibacterial effect of streptomycin up to
30–52% [115].
4.2.4. Eucomisautumnalis
E. autumnalis of the Asparagaceae family is a deciduous, summer-growing bulb char-
acterized by its extraordinary floral arrangement with wavy, soft, and fleshy flowers [86].
They are widely distributed in open grasslands and marshes across all the provinces of
South Africa, as well as some neighbouring countries like Botswana, Zimbabwe, and
Malawi [84]. Although the bulb is believed to be toxic if consumed on its own, a decoc-
tion prepared in water or milk is safe for treating fevers, urinary diseases, lower back-
aches, syphilis, and at times used to induce labour [84]. Many constituents, including
homoisoflavanones, terpenoids, and diben-α-pyrones, have been reportedly isolated from
this plant [85]. The traditional use of E. autumnalis as anti-inflammatory agents is popularly
accepted, hence, it is recommended for the manufacture of non-steroidal anti-inflammatory
drugs [84]. It is traditionally used to treat wounds, fractures and to relieve pain often
associated with surgical procedures [84].
The phytochemicals present in water extract of E. autumnalis plant were used for the
reduction of AgNO3 to AgNPs [86]. The resulting brownish-black colour connotes the
formation of AgNPs [40]. The UV-Vis spectrophotometric analysis of the formed MNPs
gives SPR bands at 423 nm, confirming the presence of AgNPs.FTIR analysis of biosyn-
thesized AgNPs signals the contribution of olyphenols and aromatic compounds in the
bioreduction process. The biosynthesized E. autumnalis AgNPs revealed the hydrodynamic
size of 56 nm and predominantly spherical shape AgNPs. These AgNPs were further
evaluated for their antimicrobial activities against Listeria monocytogenes, Enterococcus
faecalis, K. pneumonia, and Acinebacter baumannii. The result indicates that the AgNPs
displayed enhance antimicrobial effects over its bulk plant extracts in all test stains [86].
Consequently, this finding revealed that E. autumnalis AgNPs have promising antibacterial
properties against bacteria strains.
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4.2.5. Plumbago auriculata
P. auriculata is a bushy evergreen shrub belonging to the family Plumbaginaeae. It
is a native South African plant but is also distributed in other tropical and subtropical
regions of the world, including Sri Lanka and India [88]. In South Africa, P. auriculata is
predominantly found in the Southern and Western Cape to the balmy subtropical province
of Kwazulu-Natal. It is commonly known as Cape leadwort in English or blousyselbos in
Afrikaans [87]. Traditionally, P. auriculata is used to treat headaches, warts, skin infections,
wounds, and fractures [88]. The plant is reported to contain a wide range of phytochemi-
cals, including tannins, phenols, alkaloids, saponins, flavonoids and, proteins. Bioactive
compounds including plumbagin, α-amyrin, capensisone, and diomuscinone have been
isolated from the plant [88]. A study shows that most of the pharmacological activity, in-
cluding antimicrobial, anticancer, and anti-inflammatory effects of the plants, is conferred
by its biomarker compound plumbagin [88]. Plumbagin is an effective inhibitor of cell
growth, displaying a broad-spectrum anticancer effect against a wide range of cancers,
including breast, liver, prostate, pancreatic, and ovarian cancers [88].
Earlier, the successful synthesis of AgNPs from P. auriculata leaf and calyx extracts
had been reported [7]. In the study, the bioreduction of Ag+ ions by the aqueous extracts
was demonstrated in an eco-friendly manner. In the process of synthesis, a colour change
from yellowish-brown to dark brown and light yellow to dark brown was observed for the
leaf and calyx extracts, respectively. The colour change confirmed the bioreduction of Ag+
to Ag0 [35]. The biogenic AgNPs so produced denoted by the appearance of absorption
peaks between 420 and 460 nm. The AgNPs were relatively spherical to oblong in shape
with a core size diameter of 15.22 and 26.5 nm for leaf and calyx extracts, respectively. FTIR
spectra revealed that the phytochemicals containing -OH and C=O groups in both extracts
were involved in the bioreduction and stabilization of AgNPs [35]. The antibacterial
activities of both biogenic AgNPs revealed their desirable antibacterial effects against
E. coli, K. pneumoniae, S. typhimurium, and S. aureus as compared to their respective bulk
plant extracts. The study was the first to report the antibacterial activities of AuNPs using
water extracts of P. auriculata against gram-positive and gram-negative multidrug resistance
bacteria [7]. Consequently, the effective antibacterial activity of the biogenic AuNPs opens
a new path in antibacterial drug discovery.
4.2.6. Catharanthus roseus
C. roseus, also known as Madagascar periwinkle or Vinca rosea, is a well-studied medic-
inal plant. It is a perennial herb characterized by a woody base with glossy bright green
leaves and pink to white flowers [116,117]. C. roseus originated from Madagascar and was
imported to South Africa as an ornament, but has now become widely distributed in major
parts of South Africa including KwaZulu-Natal, Limpopo, and Gauteng Provinces [118].
C. roseus has been extensively studied and shown to contain over 130 phytochemicals with
vindoline implicated as its principal marker compound [119]. Other major constituents
isolated from C. roseus include vincristine and vinblastine which are well-known anticancer
drugs used for treating Hodgkin’s lymphoma and leukemia [120]. Most of the alkaloids
isolated from this plant include deoxyvinblastine, vincoline, cathanranthamine, rosicine,
and leurosine have diverse pharmacological activities [117].
Traditionally, a decoction made from leaf extracts is used to treat rheumatism, venereal
diseases, skin infections, high blood pressure, diabetes mellitus, and many others [26,90].
In Madagascar, the extract from the plant is used as purgative, vomitive, and for relieving
toothache [118,121]. Antioxidant and pharmacological activities of C. rosues such as
antidiabetics, antimicrobial and anti-inflammatory activities, have been reported. The
wound healing potential of ethanolic leaf extracts of C. roseus showed an enhanced wound
contraction in Wistar rats [122]. Verma and Singh [121] reported the antimicrobial influence
of leaf extract of C. roseus against S. citreus, S. aureus, E. coli, and P. aeruginosa, indicating
C. roseus as an excellent antibacterial agent.
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Different parts of C. roseus, including stem, root, leaf, and flower, have been explored
for the synthesis of AgNPs. For example, an eco-friendly synthesis of AgNPs using aqueous
leaf extract of C. roseus was reported [41]. Here, the bioactive constituents of C. roseus leaf
extracts were used to reduce silver salt for the synthesis of C. roseus AgNPs. The observed
colour change from light yellow to brown following incubation of C. roseus leaf extract
and AgNO3 solution indicated the reduction of Ag+ to AgNPs. This was confirmed by the
appearance of an absorption peak at 425 nm. Additional characterization revealed biosyn-
thesized AgNPs of an average size of 49 nm having crystalline nature. FTIR techniques
adopted to investigate the plausible mechanism behind the formation of these AgNPs
revealed the presence of amide group possibly contributed by enzymes/proteins present
in the plant extract. These compounds were proposed to be responsible for the reduction
of AgNO3 to AgNPs. The antioxidant activity of the biogenic crystalline AgNPs investi-
gated using 2,2-Diphenyl-1-picrylhydrazyl (DPPH)-free radical scavenging assay showed a
dose-dependent increase in the DPPH inhibition percentage up to 82% at 300 µg/mL. Also,
these AgNPs showed good antimicrobial effects against E. coli, K. pneumoniae, P. aeriginosa,
S. aureus, C. koseri, and C. albicans when compared to the plant extract or AgNO3 alone [75].
Further study revealed the wound-healing activity of the biosynthesized NPs as it had en-
hanced wound closure and reduced wound size in male albino mice compared to untreated
animals with no evidence of microbial contamination [41].
Another study reported an eco-friendly approach for the synthesis of AgNPs from the
aqueous root extract of C. roseus in the presence of silver nitrate [26]. A colour change from
light yellow to dark brown indicated the presence of AgNPs, which was confirmed by SPR
at 423 nm. The resulting spherical shaped AgNPs with sizes ranging between 35 and 55 nm.
FTIR analysis indicates the presence of alkanes and aliphatic amines, which were believed
to be responsible for the bioreduction and stabilization of the AgNPs. These AgNPs were
evaluated for their larvicidal activity against fourth instar larvae of Aedes aegypti and
Culex quinquefasciatus and it was observed that the biogenic AgNPs had enhanced larval
mortality effect when compared to C. roseus root extracts [26]. Thus, the study revealed the
potential of AgNPs synthesized using C. roseus as strong anti-larvalcidal agents.
Similarly, AgNPs synthesized using an aqueous extract of C. roseus flower were re-
ported. FTIR spectra indicate the presence of aldehydes, carbonyls, alcohols, phenols,
alkanes, and aliphatic amines. The spherical-shaped biosynthesized AgNPs having an
average size ranging between 6 and 25 nm showed remarkable antibacterial activity against
E. coli, S. aureus, K. pneumonia, and B. subtilus [75]. Other parts of C. roseus including stem
have also been explored for the synthesis of AgNPs and their antimicrobial activity has
been documented. Given the high efficacy of AgNPs of C. roseus as strong antibacterial,
antioxidant, antilaraicidal, and wound healing agents, it is recommended that other bio-
logical applications including anticancer property and the synthesis of other metallic NPs
should be investigated.
4.2.7. Aspalathus linearis
A. linearis, belonging to the family Fabaceae, is an endemic South African plant widely
distributed in the Western Cape Province of the country. A. linearis is cultivated to brew the
popular herbal Rooibos tea. It is frequently used traditionally to treat insomnia, stomach
cramps, allergies, digestive problems as well as to improve appetite [21]. Previous and
recent in vitro and in vivo studies have implicated A. linearis as a rich source of phenolic
compounds. Bioactive compounds viz, aspalathin, orientin, isoquercitrin, luteolin, and
hyperoside have been reportedly isolated from A. linearis [78,93,111]. These are believed to
be responsible for their antioxidant, immunomodulatory, anti-inflammatory, antidiabetic,
and chemoprevention effects [93].
The synthesis of AuNPs using A. linearis tea leaves to optimize the antifungal activity
of some commercial antifungal discs has been documented [87]. In this study, a green route
approach was attempted for the synthesis of AuNPs from the A. linearis plant where the
aqueous plant extract was mixed with NaAuCl4 and stirred for 30 min at room temperature.
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A colour change from yellow to ruby-red in the reaction mixture indicating the formation of
AuNPs showed a strong resonance peak at 529 nm. The biogenic AuNPs with an average
size of 44 nm, demonstrated excellent in vitro stability in different biological media at
varying pH levels [94]. The resulting biogenic AuNPswere investigated for their enhanced
antifungal activities against Aspergillus spp using disc diffusion assay. In this particular
study, the AuNPs were coated around eight commercial antifungal discs (clotimazole,
nystatin, flucytosine, fluconazole, econazole, ketoconazole, miconazole, and amphotericin)
and their zones of inhibition were compared to those coated with pristine. The AuNPs
attached better onto the antifungal disc compared to the pristine coated antifungal disc
resulting in an enhanced antifungal activity against Aspergillus spp. This study revealed
AuNPs as good antifungal agents that could be of importance in medical and veterinary
applications. The later part of their study investigated the toxicity of the biosynthesized
AuNPs against human Hep-G2 liver cancer cells, and the result indicated that the AuNPs
showed no significant effect on the cells [94].
The aqueous leaf extract of A. linearis was also used for the synthesis of rhodium (Rh)
NPs at room temperature [29]. The disappearance of the deep orange colour typical of
Rh precursor to a lit orange, following the addition of the Rh precursor to the aqueous
extract of A. linearis, indicated the formation of RhNPs [29]. The A. linearis extracts showed
near-infrared (NIR) absorbance in the optical range of 225–600 nm, however, the peak
almost completely disappeared in the presence of the RhNPs which is as a result of the
reduction of RH3+ to Rh0 [29]. The RhNPs were non-agglomerated and had an average
size of approximately 1.2 nm. Further characterization revealed that the RhNPs were
amorphous [29]. Apart from RhNPs, other metallic NPs, including zinc oxide and cobalt,
have been reportedly synthesized from A. linearis and fully characterized [123], but nothing
is reported regarding their biological applications.
4.2.8. Indigofera tinctoria
I. tinctoria, belonging to the Fabaceae family, is an erect, branched perennial plant
found predominantly in widespread tropical Africa. The plant is characterized by its
greyish-brown stem and dark-green leaves [124]. I. tinctoria species is reported to be a major
source of the colour indigo, and the leaves have widely been cultivated, extracted, and
processed for the production of indigo dye [95]. Leaf infusion of I. tinctoria is traditionally
used to treat epilepsy, asthma, stomachache, bronchitis, and some skin diseases. An
investigation of its phytochemical contents revealed that the plant contains reducing
sugars, saponins, carbohydrates, alkaloids, flavonoids, and phenolic compounds [96].
Recently, Vijayan et al. [97] reported the first-time synthesis of AuNPs from aqueous
leaf extract of I. tinctoria. A change in colour from light yellow to violet after 30 s of
exposure to microwave irradiation was observed for the AuNPs, which was later con-
firmed by an SPR peak at 545 nm. Further characterization regarding the morphology
of the AuNPs revealed that the NPs were crystalline in nature, triangular, spherical, and
hexagonal, and having a particle core size ranging between 6 and 29 nm [97]. An investiga-
tion of the antibacterial and antifungal activities of the AuNPs revealed some degree of
antimicrobial effects against B. pumilis, S. aureus, P. aeruginosa, E. coli, Aspergillus fumigatus,
and Aspergillus niger with noticeable zones of inhibition. In addition, the study further
evaluated the anticancer effect of I. tinctoria AuNPs on human lung (A549) cells using
the 3-[4,5-dimethythiazol-2yl]-2,5 diphenyl tetrazolium bromide (MTT) assay. The result
revealed that the biogenic I. tinctoria AuNPs showed enhance toxicity against lung cancer
(A549) cells with evident changes (shrinking) in cellular morphology compared to the
bulk plant extract [97]. Therefore, the findings from this study clearly showed that AuNPs
synthesized from water extracts of I. tinctoria can be effectively used as powerful weapons
against cancer cells, particularly lung cancer as well as against bacteria cells.
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4.2.9. Artemisia herba-alba
A. herba-alba, also known as the white wormwood, is a perennial shrub that grows
commonly on the dry steppes of the Mediterranean regions in Northern Africa, Western
Asia, and South-Western Europe [21]. Its leaves are strongly aromatic and covered with
fine glandular hairs. It is used as an antiseptic and antispasmodic, as well as a treat-
ment for anorexia, indigestion, and gastrointestinal problems [99]. Major constituents of
A. herba-alba include 1,8-cineole and appreciable amounts of alpha and beta-thujone as
well as other oxygenated monoterpenes in addition to davanone, chrysanthenone, and
cis-chrysanthenol [125]. Phytochemical investigation of the aerial part of A. herba-alba
revealed two new natural sesquiterpene lactones [102] in addition to artemisin, an en-
doperoxide sesquiterpene lactone and the quaianolide structural type. These compounds,
particularly those isolated from its essential oil, tend to provide Artemisia with a wide
range of bioactivity, including antibacterial, antiseptic, antifungal, and choleretic activi-
ties [126]. A. herba-alba is commonly used as a remedy for enteritis, menstrual pain, nervous
problems, and various intestinal disturbances among the Bedouins in the Negev desert
of Israel [21,101]. Essential oil from this plant showed antibacterial and antispasmodic
activities in rabbits [120]. Also, an aqueous extract of aerial parts of the plant with a
hypoglycemic effect in alloxan-induced diabetic rabbits and mice has been reported [98].
The first record of A. herba-alba mediated synthesis of AgNPs was reported [101]. The
appearance of a yellowish-brown suspension following the mixing of AgNO3 solution with
the water extracts of A. herba-alba, in addition to the peak at 425 nm, indicated the formation
of AgNPs. Further characterization of the fabricated A. herba-alba AgNPs revealed spherical
shaped NPs with a size range of 43 and 74 nm. FTIR analysis of the fabricated AgNPs
indicated relevant absorption peaks corresponding to N-H stretching from peptide linkages
and C-C stretching vibrations of aromatic amines. The fabricated AgNPs were tested on
Indian and Saudi Arabian strains of Anopheles, Aedes, and Culex mosquitoes and reported
to be a source of green nanoinsecticides against mosquito vectors [123]. Also, the bacteria
growth inhibition effect of the biogenic A. herba-alba AgNPs was demonstrated against
B. subtilis, K. pneumonia, and S. typhi. This study proposed that the fabricated A. herba-alba
AgNPs have relevant insecticidal and bactericidal activities against species of high public
health importance [101].
4.2.10. Cantella asiatica
C. asiatica is a herbaceous, perennial plant native to South Africa, Asia, and the South
Pacific. In South Africa, the decoction of C. asiatica is used to treat fever, leprosy, syphilis,
tuberculosis, asthma, epilepsy, mental disorder, minor wounds, and it is also consumed
as a vegetable and used as a spice [21]. C. asiatica has been extensively studied to contain
pentacyclic triterpenoids, centellose, centelloside, and medacassoside, which are believed
to proffer its healing potential [103]. The major chemical constituents found in this plant are
triterpene saponosides, flavonoid derivatives viz quercetin, rutin, kaemferol, patuletin, api-
genin in addition to polysaccharides, polyacetylenes, phenolic acids, and sterols [103]. An
investigation of the neuroprotective activity of C. asiatica demonstrated that the plant can
inhibit acetylcholinesterase, a key enzyme implicated in the pathogenesis of Alzheimers dis-
ease [127]. Moreover, the wound healing property of ointment, cream, and gel formulated
from aqueous extract of this plant showed enhanced wound healing properties in Wistar
rats by increasing collagen content and tensile strength at the wound site [128]. Other stud-
ies also documented the cognitive-enhancing, antioxidant, antidepressant, antiepileptic,
sedative, and anxiolytic properties of C. asiatica.
The synthesis of AgNPs using aqueous leaf extracts of C. asiatica L. was developed
by Rout and colleagues [104]. Upon incubation of plant extracts with silver salt at room
temperature, stable AgNPs were produced without the involvement of toxic chemicals as
capping agents. Biosynthesized AgNPs were spherical with a size range between 30 and
50 nm. Agar well diffusion assay revealed effective antimicrobial activity of biosynthesized
C. asiatica AgNPs against S. aureus [104].
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In a similar study, Thakkar et al. [62] synthesized AgNPs using aqueous leaf extracts
of C. asiatica. In this particular study, the antimicrobial activity of both the aqueous extracts
of C. asiatica and its resulting AgNPs were compared against S. aureus, P. aeruginosa, and
E. coli. Results showed that leaf extracts of C. asiatica had low activity compared to those
exhibited by its biogenic AgNPs. This finding suggests that C. asiatica AgNPs interact
with the bacteria cell wall more than the extracts and thus describe the AuNPs as stronger
antimicrobial agents compared to its bilk plant extract [62].
4.2.11. Galenia africana
G. africana is a major group of flowering plants belonging to the family Aizoaceae.
G. africana commonly referred to as kraalbos, geelbos, or perdebos, is found abundantly in
Namaqualand, Northern Cape, some parts of Karoo, and Eastern Cape Province of South
Africa. The plant is characterized by leaves growing in the opposite direction, soft woody
shrublet (0.5–1.5 m high), and acute apex flowers. The plant is used to treat venereal sores,
eye infections, asthma, tuberculosis, cough, wounds, and skin infections. Locals masticate
the leaves of G. africana to relieve toothache [105]. The earlier phytochemical investigation
reported by Mativandlela et al. showed three known flavonoids viz, trihydroxyflavanone,
trihydroxychalcone, dihydroxychalcone, and a new trihydroxy-3-methoxychalconeare
present in the G. africana [106].
The first-time synthesis of AuNPs from G. africana was demonstrated by [25], where
the phytochemicals present in aerial parts of G. africana were utilized for the reduction of
gold salts to form Galenia-AuNPs. The change in colour from light yellow to red colour
following a 1 h incubation at 70 ◦C indicated the appearance of Galenia-AuNPs [25]. The
AuNPs had absorption spectra at 534 nm with varying shaped crystalline AuNPs with
core sizes ranging between 9 and 27 nm. The different shapes were an indication that
different bioactive compounds present in the plant extract actively participated in the
reduction process as equally revealed by FTIR. The biogenic AuNPs were stable in various
biological media and exhibited antibacterial effects against S. aureus, E.coli, S. epidermidis,
and P. aeruginosa. These microbes are very common in wound infections, consequently
Galenia-AuNPs could be recommended as potent treatment regimen for wound infec-
tions. To address the toxic effects of biogenic AuNPs in non-cancer cells, this particular
study further reported that the Galenia-AuNPs have excellent biocompatibility in KMST-6
cells [25]. The Galenia-AuNPs at a concentration of 32 µM following a 24 h treatment
showed no significant reduction in the cell viability [25]. On the other hand, Hossain
et al. [129] investigated the toxic effect of biogenic AgNPs synthesized from water extract
of Andrographis paniculata stem in healthy male Wistar rats. The result showed that there
was no significant toxic effect on the liver and kidneys following an intravenous treatment
of the rats with either 2 mg/kg or 5 mg/kg body weight. More specifically, there was no
significant difference in serum biomarkers and creatine levels between the treated and
control animals [129]. Thus, biogenic MNPs are believed to offer excellent biocompatibility
and can be recommended for future therapeutic applications [25].
4.2.12. Sclerocarya birrea
S. birrea is a medium-sized to a large deciduous tree with an erect trunk, having its
leaves mostly crowded at the end of the branches. The plant is commonly found in riverine,
grasslands, and bushlands as well as in well-drained, loamy, and sandy soil [67]. S. birrea is
predominantly found in the Phalaborwa area in Limpopo [107]. Traditionally, the decoction
of S. birrea is used to treat dysentery, rheumatism, malaria, and diarrhea [108]. The leaves
are eaten as vegetables, while the fruits and plums, including alcoholic drinks, jams,
and juice produced from the plant, are consumed in most countries of West Africa [108].
Medicinal value credited to this plant is traced to their secondary metabolite contents,
including glucosides, steroids, glycosides, flavonoids, fatty oils, alkaloids, phenols, resins,
calcium, and phosphorus. Moreover, traditional healers in West Africa use the infusion
prepared from the stem bark of the plant to treat diabetes [108].
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In an earlier study, Lediga and colleagues explored the phytochemicals present in
S. birrea plant extracts for the synthesis of AgNPs [86]. The resulting brownish-black colour
in the reaction medium confirmed the formation of AgNPs which was confirmed by the
SPR band at 440 nm. The FTIR analysis of biosynthesized AgNPs indicated the presence
of polyphenols and aromatic compounds, which were believed to play major roles in
the bioreduction process. The hydrodynamic size of 112 nm for S. birrea AgNPs with
predominantly spherical NPs. The AgNPs NPs were evaluated for their antimicrobial
activities against L. monocytogenes, E. faecalis, K. pneumonia, and A. baumannii. The result
displayed the enhanced antimicrobial effect of S. birrea AgNPs over its bulk plant extracts
exhibiting the highest inhibition against A. baumannii [86].
4.3. Preclinical and Clinical Application of MNPs
Despite the highlighted potential of biosynthesized MNPs, very few of them have
been critically evaluated for in vivo purposes [130] and only one was evaluated in hu-
man trials [73]. This suggests that many of the MNP formulations have not sufficiently
accomplished the pharmaceutical regulation to warrant their clinical application [131].
Nonetheless, pre-clinical studies so far have provided compelling evidence of the poten-
tial clinical application of the biogenic MNPs. Some of their biomedical applications are
highlighted in Section 2, where they are used as antimicrobial, wound healing [41], drug
delivery [20,73], and therapeutic agents [19,28]. The outcomes of these nanomaterials, sup-
ported by the longstanding use of the medicinal plants further encourage their translation
into clinical practice. In fact, the biogenic AgNPs have potential to replace the chemi-
cally synthesized MNPs due to their biocompatibility. Additionally, the biosynthesized
MNPs are capable of targeting and killing diseased cells without attaching targeting and
therapeutic moieties [19].
The wound healing property of biogenic C. roseus AgNPs was reported in mice.
Further, the study observed sign of microbial contamination, pus formation, inflamma-
tion and bleeding in untreated mice, whereas, mice treated with the C. roseus AuNPs
showed none of these symptoms [41]. Independent studies demonstrated the anti-tumor
effect of AuNPs loaded with resveratrol (RES-AuNPs) in breast (MDAMB-231), pancreatic
(PANC-1), prostate (PC-3) cancer cells [76], as well as in mice bearing liver tumours [132].
In both studies the RES-AuNPsexhibited stronger anti-tumour effect when compared to
free resveratrol [76,132]. MGF-AuNPs were the extensively studied, and demonstrated
to have antitumor effects on various cancer cells alone [74] or in combinanation with
chemotherapeutic drugs [20]. MGF-AuNPs was also shown to significantly reduce tu-
mour volumes in mice implanted with PC-3 tumour xenografts within three weeks of
administration. This particular study further revealed that 80% of the intratumoural ad-
ministered radiolabelled MGF-AuNPs were localized in the tumour site within 30 min of
treatment and this was maintained for 24 h [74]. These encouraging pre-clinical results
prompted the work of Khoobchandani et al. [73] that investigated the clinical efficacy of
biogenic MNP formulation in metastatic breast cancer patients. The study established
Nano Swarna Bhasma (NSB), a nanodrug prepared through the proprietary combinations
of phytochemicals from Emblica officinalis, Mangiferaindica, Curcumin longa, Acacia
nilotica, and Glycyrrhiza glabra with the AuNPs synthesized using Mangifera indica peel
extract [73]. The NSB exhibited selective toxicity against human breast (MDA-MB-23)
cancer and non-cancer aortic endothelial (HAEC) cells [73], and reduced tumour size in
Severe Combined ImmunoDeficient mice. More importantly, the study also reported sig-
nificant therapeutic benefits in breast cancer patients treated with NSB and these benefits
were more pronounced when used in combination with antitumour drugs (doxorubicin
and cyclophosphamide). Although, NSB is the first biogenic MNP to be used in human
trials [73], there are a number of other MNPs that have been approved by the Food and
Drug Administration (FDA) for clinical trials. These include AuNPs approved for cancer
(NCT00356980), diabetes (NCT02837094), dental (NCT03669224), and skin (NCT02219074)
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therapy; AgNPs for skin infections (NCT03752424); and iron oxide NPs for cancer therapy
(NCT02033447) and imaging (NCT04261777).
5. Conclusions and Future Perspectives
It is evident from literature that biogenic MNP formulations undeniably have broad-
spectrum propensity against a wide array of diseases, however, their translation into
conventional medicine suffers from a number of drawbacks, particularly the lack of in-
formation regarding their fate in vivo. According to literature, various biological models
incorporating plants, mammalian cells, microorganisms, fish and mammals have been
used to evaluate the toxicity of plant mediated MNPs, yet none has been able to sufficiently
establish the exact mechanism involved in their toxicity. On the other hand, quite a number
of pre-clinical/clinical investigations have evidently reported interesting antimicrobial,
wound healing, anticancer, antioxidative, anti-inflammatory, immunomodulatory, and
cytotoxic activities of these biogenic MNPS. It is therefore recommended that considerable
efforts need to be devoted towards assessing the efficacy and safety of these natural MNP
formulations in clinical research. More importantly, detailed description of the methods
for the synthesis, purification, exact composition of the MNP formulations as well as the
dosage should strictly be provided to allow for its reproductivity. In this regard, MNP
formulations composed mainly of biological material could serve as better options over
chemically synthesized MNPs, thus their translation into conventional medicine could
be much faster, with the benefit to overcome the many challenges associated with the
present-day standard modes of treatment.
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